Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)

OSLO, Norway, Feb. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Lig... Devices, Oncology, FDA Photocure, KARL STORZ, Blue Light Cystoscopy, Cysview, bladder cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news